These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Thrombopenia during 5-ASA treatment (mesalazine and olsalazine)]. Benoit R; Grobost O; Bichoffe A; Dol L Gastroenterol Clin Biol; 1999 Mar; 23(3):410-1. PubMed ID: 10384350 [No Abstract] [Full Text] [Related]
10. Cutaneous hypersensitivity reaction to mesalazine. Aparicio J; Carnicer F; Girona E; Gmez A Am J Gastroenterol; 1996 Mar; 91(3):620-1. PubMed ID: 8633534 [No Abstract] [Full Text] [Related]
11. Mesalazine induced exacerbation of ulcerative colitis. Kapur KC; Williams GT; Allison MC Gut; 1995 Dec; 37(6):838-9. PubMed ID: 8537058 [TBL] [Abstract][Full Text] [Related]
12. [Fever and hypotension following oral administration of mesalazine]. Galofré N; Cirera I; Supervía A; Peña MJ Med Clin (Barc); 1995 Mar; 104(9):358. PubMed ID: 7731308 [No Abstract] [Full Text] [Related]
13. The risk of sulfasalazine- and mesalazine-associated blood disorders. Jick H; Myers MW; Dean AD Pharmacotherapy; 1995; 15(2):176-81. PubMed ID: 7624265 [TBL] [Abstract][Full Text] [Related]
14. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity]. Loizeau E Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252 [No Abstract] [Full Text] [Related]
15. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease]. García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266 [TBL] [Abstract][Full Text] [Related]